Shares of Open Orphan Plc (LON:ORPH – Get Free Report) shot up 5.3% on Thursday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.12). 652,639 shares traded hands during trading, a decline of 58% from the average session volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Stock Up 5.3 %
The company has a quick ratio of 1.16, a current ratio of 1.19 and a debt-to-equity ratio of 10.88. The stock has a 50 day simple moving average of GBX 10 and a 200 day simple moving average of GBX 10. The stock has a market cap of £67.09 million and a price-to-earnings ratio of -25.30.
Open Orphan Company Profile
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than Open Orphan
- Short Selling: How to Short a Stock
- Hasbro’s Management Made All the Right Calls This Quarter
- Profitably Trade Stocks at 52-Week Highs
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Invest in Biotech Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.
